NCT00934518 2019-02-12Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell CarcinomaMilton S. Hershey Medical CenterPhase 2 Withdrawn